BEAM CropTech uses CRISPR‑based editing of a conserved plant gene to boost photosynthetic efficiency, delivering faster growth and higher yields across multiple crops. The non‑transgenic Photosynter trait is licensed to major seed companies, which integrate it into elite varieties and pay royalties based on commercial performance.

BioMetallum specializes in biomining technology that utilizes genetically modified microorganisms to extract lithium and other metals without harmful chemicals. This approach enhances extraction efficiency, conserves freshwater resources, and minimizes environmental impact in the mining industry.

Biotalife Skin provides personalized skincare by analyzing your unique skin microbiome through DNA sequencing and AI. The platform identifies your skin's microbial composition to predict conditions and develop tailored treatments for optimal skin health.

This biotechnology startup is developing miRNA-based therapeutic products that target gene expression in the joint microenvironment to treat degenerative articular diseases. By utilizing small RNAs, the company aims to modify disease progression and provide a new treatment pathway for patients suffering from these conditions.

Eiru provides a unified data analytics platform that simplifies data ingestion, analysis, and visualization for enterprises. It enables users to consolidate diverse data sources and leverage advanced analytical tools to uncover insights and drive informed decision-making.

This company develops a modular platform for the on-demand self-assembly of smart, multifunctional nanobiomaterials. Guided by a One Health approach, they are building business units focused on disease detection, prevention, and treatment. Their proprietary technology leverages expertise in protein engineering, immunology, and vaccinology to address global health challenges.

Exomas develops treatments for neurodegenerative diseases using neural stem cell-derived exosomes (CBSD-EXO). This technology stimulates the proliferation of existing neural stem cells and promotes neuroplasticity by generating new neurons. The goal is to restore mental and motor functions impaired by neurological damage.

This biotechnology startup develops a micro device that emulates natural sperm selection and maturation processes to optimize human embryo production. The technology simplifies assisted reproduction techniques by standardizing procedures within a single, easy-to-use system. This approach aims to improve sperm quality, enhance embryo quality, and increase overall treatment success rates for fertility clinics.

The startup has developed a molecular testing platform that utilizes low-cost tools for on-site analysis of DNA, RNA, and protein targets. This technology enables businesses to make real-time decisions regarding food quality and health by providing precise and accessible testing services.

MesencHyal-T develops advanced cell therapies for bone regeneration using allogeneic mesenchymal stem cells and hyaluronic acid. Their AI-powered platform optimizes treatment for bone injuries and degenerative conditions, offering scalable, ready-to-use products for improved healing and patient quality of life.

Microbesforlife provides a non‑GMO, seed‑coating product that delivers bio‑trained microbes—selected for drought, heat and salinity tolerance—directly to the rhizosphere. The proprietary formulation protects the microbes on the seed, extending shelf life and enhancing plant growth, biomass and nodulation, which has shown 10‑28% yield gains in field trials. The solution is compatible with existing agronomic practices and targets agribusinesses, seed producers and large‑scale farmers seeking sustainable stress mitigation.

NotFossil provides biotechnology solutions for hydrocarbon bioremediation in industrial wastewater treatment. Their services help companies remove petroleum-based contaminants from water, ensuring compliance with environmental regulations and promoting sustainable waste management.

Oncoliq develops a liquid biopsy method utilizing microRNA detection for the early diagnosis of breast, prostate, and other cancers through a simple blood test. This technology addresses the critical issue of late cancer detection, aiming to identify up to 50 types of cancer, thereby significantly improving treatment outcomes and reducing mortality rates.

PILL.AR offers a digital platform that lets physicians design personalized medication regimens and automatically generates a single 3D‑printed capsule containing the exact combination and dosage for each patient. The system integrates dose‑optimization algorithms, pharmacy workflow, and real‑time traceability to ensure precise dosing, safety, and adherence monitoring across the health network.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

TELL Toolkit utilizes AI-driven analysis of natural speech patterns to provide objective metrics for early detection of brain disorders and neurocognitive decline. This technology offers real-time insights for clinical and educational settings, enhancing assessments of language development and cognitive health.

Tintte develops smart bio-dyes engineered to replace petrochemical dyes in industrial applications. These sustainable colors are derived from renewable resources, offering consistent performance and high fastness comparable to conventional pigments. The process utilizes lower energy and water, enabling effortless adoption into existing textile workflows while eliminating toxic chemical discharge.

Trebe Biotech utilizes insect larvae as biofactories to produce high-quality recombinant proteins and vaccines, offering a sustainable and cost-effective alternative to traditional bioreactor methods. This approach addresses the need for rapid production of bioproducts, particularly in response to emerging health challenges in both human and veterinary medicine.

Unibaio develops advanced biomaterials using natural polymers like chitosan derived from sustainable sources. The company engineers microparticles and hydrogels for applications in tissue engineering and agriculture. These materials function as carriers and additives to enhance cell growth, protect active ingredients, and improve soil moisture control.